Skip to main content
Screener/Healthcare/Biotechnology

RCUS — Arcus Biosciences, Inc.

NYSE
$28.12-0.14 (-0.50%)
Mid CapUnder $50Healthcare
$8.84
$31.73
$27.25
$28.37
EPS (TTM)$-3.17
P/E Ratio-7.55
Dividend Yield—
Market Cap$3.40B
Volume809K
Prev Close$28.25
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$17.0M-$128.0M$-1.020.0%-752.9%
Q4 '25$33.0M-$98.0M$-0.9290.9%-297.0%
Q3 '25$26.0M-$135.0M$-1.2792.3%-519.2%
Q2 '25$160.0M-$8.0M$0.04100.0%-5.0%
Q1 '25$28.0M-$112.0M$-1.14100.0%-400.0%
Q4 '24$26.0M-$94.0M$-1.03100.0%-361.5%
Q3 '24$48.0M-$92.0M$-1.01100.0%-191.7%
Q2 '24$39.0M-$93.0M$-1.02100.0%-238.5%
Get Your Daily Market Recap